PUBLISHER: Grand View Research | PRODUCT CODE: 1571759
PUBLISHER: Grand View Research | PRODUCT CODE: 1571759
The global robotic endoscopy devices market size is expected to reach USD 4.46 billion by 2030, registering a CAGR of 8.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising preference for Minimally Invasive Surgical (MIS) procedures, recent product approvals by the regulatory bodies such as the U.S. Food and Drug Administration (FDA), and prevalence of chronic diseases are the key factors driving the growth.
Robotic endoscopy devices are developed to overcome the limitations of standard diagnostic and therapeutic procedures. The benefits of robotic endoscopy devices in surgical procedures include fast recovery time, reduced post-surgery complications, and minimized scars, thus reduced the duration of hospital stays. Such benefits are anticipated to drive the robotic endoscopy devices market in the forthcoming years.
Factors such as new product developments, approvals, and technological advancements are projected to further fuel the market growth. For instance, in March 2018, Auris Health (Johnson & Johnson) announced the FDA clearance for its Monarch Endoscopy platform. The robotic endoscopy system developed by Medineering GmbH received CE mark approval in the European Union in 2016. Medineering also received the CE approval for its endoscope robot in February 2018.